Methods of data collection and analysis for the economic evaluation alongside a national, multi-centre trial in the UK: Conventional ventilation or ECMO for Severe Adult Respiratory Failure (CESAR)
暂无分享,去创建一个
Nicola J Cooper | Miranda Mugford | Ravindranath Tiruvoipati | Felicity Clemens | M. Mugford | D. Elbourne | N. Cooper | G. Peek | R. Tiruvoipati | Giles J Peek | Andrew Wilson | Diana R Elbourne | Mariamma M Thalanany | Ann Truesdale | Clare Hibbert | Steven Robinson | Polly Hardy | F. Clemens | P. Hardy | C. Hibbert | A. Truesdale | M. Thalanany | A. Wilson | Steven Robinson | Mariamma M. Thalanany
[1] P. Aegerter,et al. A cost-effectiveness analysis of stays in intensive care units , 2001, Intensive Care Medicine.
[2] J. Goodier. Health Survey for England 1995 , 1997 .
[3] M. Mugford,et al. Visiting adult patients in intensive care: the importance of relatives' travel and time costs. , 2006, Intensive & critical care nursing.
[4] A. B. Prasad,et al. British National Formulary , 1994 .
[5] 農林水産奨励会農林水産政策情報センター,et al. The green book : appraisal and evaluation in central government , 2003 .
[6] C. Hibbert. Development and application of a method for estimating daily case-mix adjusted costs of adult critical care units. , 2007 .
[7] D C Angus,et al. Quality-adjusted survival in the first year after the acute respiratory distress syndrome. , 2001, American journal of respiratory and critical care medicine.
[8] D. Whynes,et al. On approximations in treatment costing. , 1995, Health economics.
[9] S. Petrou,et al. Cost effectiveness analysis of neonatal extracorporeal membrane oxygenation based on four year results from the UK Collaborative ECMO Trial , 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.
[10] M Johannesson,et al. On the decision rules of cost-effectiveness analysis. , 1993, Journal of health economics.
[11] J J Osborn,et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. , 1972, The New England journal of medicine.
[12] J. Vincent,et al. Survival and Quality of Life after Prolonged Intensive Care Unit Stay , 2007, Anaesthesia and intensive care.
[13] Arthur S Slutsky,et al. One-year outcomes in survivors of the acute respiratory distress syndrome. , 2003, The New England journal of medicine.
[14] Alex J. Sutton,et al. Methods for Meta-Analysis in Medical Research , 2000 .
[15] Mark S. Roberts,et al. Understanding costs and cost-effectiveness in critical care: report from the second American Thoracic Society workshop on outcomes research. , 2002, American journal of respiratory and critical care medicine.
[16] Robert H. Bartlett,et al. Extracorporeal Life Support for Severe Acute Respiratory Distress Syndrome in Adults , 2004, Annals of surgery.
[17] P. Rycus,et al. Extracorporeal Life Support Registry Report 2004 , 2005, ASAIO journal.
[18] T. Roberts,et al. Economic evaluation and randomised controlled trial of extracorporeal membrane oxygenation: UK collaborative trial. The Extracorporeal Membrane Oxygenation Economics Working Group. , 1998, BMJ.
[19] U. Janssens,et al. Five-year survival, quality of life, and individual costs of 303 consecutive medical intensive care patients—A cost-utility analysis , 2005, Critical care medicine.
[20] T. Evans,et al. Comparison of nose and face mask CPAP therapy for sleep apnoea , 1998, Thorax.
[21] F. Jardin,et al. Improved prognosis of acute respiratory distress syndrome 15 years on , 1999, Intensive Care Medicine.
[22] A. Wilson. The British National Formulary. , 1963, The Practitioner.
[23] J. Posnett,et al. Indirect cost in economic evaluation: the opportunity cost of unpaid inputs. , 1996, Health economics.
[24] M Knapp,et al. Reduced list costings: examination of an informed short cut in mental health research. , 1993, Health economics.
[25] A H Briggs,et al. Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses , 2001, Expert review of pharmacoeconomics & outcomes research.
[26] P. Kirshbom,et al. Cost-utility analysis of salvage cardiac extracorporeal membrane oxygenation in children. , 2005, The Journal of thoracic and cardiovascular surgery.
[27] Duncan Macrae,et al. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation , 1996, The Lancet.
[28] G. Peek,et al. Extracorporeal membrane oxygenation for adult respiratory failure. , 1997, Chest.
[29] Andrew Briggs,et al. Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions. , 2004, Health economics.
[30] Tracy E Roberts,et al. Economic evaluation and randomised controlled trial of extracorporeal membrane oxygenation: UK collaborative trial , 1998 .
[31] D. Elbourne,et al. Cost-Effectiveness of Neonatal Extracorporeal Membrane Oxygenation Based on 7-Year Results From the United Kingdom Collaborative ECMO Trial , 2006, Pediatrics.
[32] A. Briggs,et al. Statistical Methods for Cost-Effectiveness Research: A Guide to Current Issues and Future Developments , 2003 .
[33] S. Wilson. Methods for the economic evaluation of health care programmes , 1987 .
[34] R. Bartlett,et al. Extracorporeal Life Support Registry Report 1995. , 1997, ASAIO journal.
[35] M. Mugford,et al. CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure , 2006, BMC Health Services Research.
[36] M. Drummond,et al. Economic Evaluation in Health Care: Merging Theory with Practice , 2002 .
[37] K. Steinberg,et al. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. , 1995, JAMA.